Published in Oncology Business Week, April 4th, 2010
"Osteoporosis, persistent after 12 years of hormone replacement therapy, and celiac disease. Management....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.